In addition, the circulating levels of CD14++CD16+ and CD14+CD16++ monocytes and M-MDSC, together with information about the immunological status of patients related to T cell responses, would contribute to differentiate more efficiently between LR-TB and HR-TB patients. This evidence concerns the gene FCGR3A and tuberculosis.